Cross-Sector entity
funding is the sole category represented across all 1 tracked stories. ASX is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Cross-Sector story that mention Vitalant, all published on June 12, 2026.
1 verified story tracked
Last mentioned: Jun 12, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
funding is the sole category represented across all 1 tracked stories. ASX is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Cross-Sector story that mention Vitalant, all published on June 12, 2026. Each carries 2 original sources on average.
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Vitalant. Shared-story counts are live from our verified record — not editorial picks.
Vitrafy Life Sciences raised $30 million in a discounted institutional placement, aiming to disrupt the US blood storage market with its Guardion integrated platform. The raise, at a 31.6% discount, funds fleet expansion and US sales ahead of a 2027 legacy technology phase-out.
Source: proactiveinvestors.com · smallcaps.com.au
